ScripAurobindo Pharma Limited ’s recently announced acquisition of 15 undisclosed branded products in Indonesia for $48m in cash from Pfizer Inc. and Viatris Inc. marks an interesting role reversal of
HBW InsightThe recent finalization of the external analgesics OTC monograph in the US will have Salonpas marketer Hisamitsu America Inc. considering innovations for the category. But first, it observed a centuri
HBW InsightMarketing Salonpas in the US as the No. 1 doctor-recommended OTC pain relief patch isn’t enough for Hisamitsu America Inc. It’s also offering health care professionals online access to information abo
HBW InsightHisamitsu America Inc. was preparing to launch a topical line extension for its Salonpas external pain relief brand that competes directly with GlaxoSmithKline plc ’s Voltaren Arthritis Pain when GSK